Panel Screening Services for Immuno-Oncology Drug Discovery
Comprehensive Panel Screening
Creative Biolabs is dedicated to offering a suite of panel screening services specifically designed for immuno-oncology drug discovery. Our sophisticated panels cover an extensive range of analyses, each tailored to meet the intricate requirements of therapeutic antibody and protein development.
Custom Panel Service
Kinase Panels
Our panels feature a broad spectrum of kinase targets, categorized into essential groups including TK, CMGC, AGC, CAMK, CK1, STE, and TKL. By utilizing these diverse kinase groups, researchers can thoroughly investigate kinase-related pathways and discover inhibitors that can be developed into therapeutic drugs.
View→
Cell Panels
At Creative Biolabs, our cell panels are designed to advance the field of immuno-oncology drug discovery and therapeutic antibody and protein development. Our DDR panels provide comprehensive screening capabilities to assess the cellular responses to DNA damage.
View→
Safety Panels
Our safety panels assess how drug candidates interact with various molecular targets to ensure that therapeutic candidates exhibit minimal off-target effects. By identifying these safety concerns early on, we help streamline the development process and reduce the risk of late-stage failure.
View→
Drug Abuse Safety Panels
One aspect of drug safety is to ensures that new drugs do not activate pathways that could lead to abuse or affect CNS integrity adversely. Our drug abuse safety panels focus on a wide range of CNS targets. They are designed to assess the potential for abuse and dependency associated with therapeutic candidates.
View→
Cellular Functional Selectivity Panels
Our expansive cellular functional selectivity panels include cutting-edge 5-HT receptor panels, CCR panels, acetylcholine receptor panels, amino acid transporter panels, and etc. These comprehensive panels enable a streamlined, high-throughput approach to identifying functional selectivity.
View→
Biochemical Selectivity Panels
Our extensive panel offerings include but not limited to ATPase panels, caspase panels, CDK panels, and DUB panels, each integral in identifying and validating potential targets with precision. These panels further empower researchers to elucidate complex biochemical interactions.
View→
Target-Specific Cell Panels
Our target-specific cell panels are meticulously designed to facilitate precise and efficient screening of various therapeutic candidates. These panels include ABL Cell Panels, ALK Cell Panels, and CDK2/4/6 Cell Panels, all of which provide a robust platform for evaluating kinase inhibitors and other therapeutic modalities.
View→
Biomarker Panels
Our biomarker panels are designed to support a wide range of drug discovery and development projects, particularly in the fields of immunology and neurology. These panels include anti-inflammatory cytokine panels, pro-inflammatory cytokine panels, CNS neural transmitter panels, and fibrosis biomarker panels.
View→
Other Panels
Besides, we also have a diverse range of other panels, providing comprehensive insights into the investigation of cancer biology and the development of targeted therapies.
View All Panels→
DDR Cell Panels
Creative Biolabs offers comprehensive DDR cell panels, a critical resource for accelerating drug discovery and research targeting the DNA damage response DDR pathway. These ready-to-use panels consist of meticulously engineered cell lines featuring specific, well-characterized genetic modifications in key DDR genes.
View→
Beyond these specialized panels, Creative Biolabs also offers customized solutions tailored to the unique needs of each research program. Our ability to adapt and create bespoke panels reflects our commitment to fostering innovation and accelerating the timeline from discovery to therapeutic application.
For more information or to discuss how our panel screening services support your research, please contact us.
For Research Use Only | Not For Clinical Use
Download our brochure
